Wegovy® Pill
The first FDA-approved oral GLP-1 for weight loss. The Wegovy® pill delivers the same semaglutide as the Wegovy® injection — in a once-daily tablet that requires no injection, no refrigeration, and is available for approximately $149/month self-pay.
Prescription required. Provider determines clinical appropriateness.
Wegovy® Pill — oral semaglutide for weight loss
The Wegovy® oral pill formulation delivers semaglutide as a once-daily tablet instead of a weekly injection. Same active ingredient as injectable Wegovy and Ozempic. Clinical trials showed weight loss comparable to or slightly less than the injectable form. Best for patients who prefer to avoid injections. Must be taken on an empty stomach with limited water and waiting 30+ minutes before eating, drinking, or other medications. The FirstCall platform connects you with an independent, board-certified physician for evaluation and prescription.
oral semaglutide (Wegovy® Pill formulation)
once-daily oral tablet, taken on empty stomach
patients who prefer oral over injectable, similar clinical effect
Educational content. Last clinically reviewed by the FirstCall Clinical Editorial Board, June 2026. The FirstCall platform provides access to independent, licensed physicians; final clinical decisions rest with the prescribing physician. Seek emergency care for severe abdominal pain, signs of pancreatitis, or severe allergic reaction.
What is the Wegovy® pill?
Wegovy® pill is once-daily oral semaglutide 25mg — the first FDA-approved oral GLP-1 receptor agonist for weight management. FDA approved on December 22, 2025, it contains the same active compound as the Wegovy® injection but in tablet form. It works by mimicking the GLP-1 hormone to suppress appetite, slow gastric emptying, and improve insulin sensitivity.
In the Phase III OASIS 4 trial, participants taking oral semaglutide 25mg once daily lost an average of 16.6% of body weight at 64 weeks with full adherence — comparable to the injectable form. One in three participants achieved 20% or greater weight loss. The pill does not require refrigeration, making it more convenient for travel and daily use.
Pill vs. injection: Both Wegovy® forms contain semaglutide and deliver comparable weight loss. The pill is taken once daily and requires no refrigeration. The injection is taken once weekly. The key pill requirement: take on an empty stomach with up to 4oz of plain water and wait 30 minutes before eating or taking other medications.
The 30-minute rule — why it matters
The Wegovy® pill uses an absorption enhancer (SNAC) to enable oral absorption of semaglutide. For this to work correctly, the pill must be taken in a very specific way — and deviating from these instructions significantly reduces effectiveness.
Take first thing in the morning before eating or drinking anything other than plain water. Stomach must be empty.
Swallow with up to 4oz (120mL) of plain water only. Do not use other beverages. Do not crush or split the tablet.
Wait at least 30 minutes before eating, drinking anything other than plain water, or taking other oral medications. This window is essential for absorption — eating or drinking early significantly reduces how much semaglutide is absorbed.
What to expect on the Wegovy® pill
Gradual dose escalation allows the body to adjust and minimizes gastrointestinal side effects.
Begin at the lowest dose. Take daily on an empty stomach, wait 30 minutes before eating. Most tolerate this dose well.
Dose increased to 4mg. Appetite suppression becomes more noticeable. GI side effects typically diminish as body adjusts.
Gradual dose escalation continues toward the 25mg maintenance dose over several months.
Full maintenance dose reached. Average 13–17% body weight loss on track. Continued treatment sustains results.
Wegovy® pill vs. Wegovy® injection
*Based on publicly available Novo Nordisk pricing. Insurance coverage and co-pays vary.
How to get the Wegovy® pill through FirstCall
Brief health intake including BMI, health history, and current medications. Takes about 10 minutes.
Physician evaluates eligibility and assists with insurance prior authorization or advises on the $149/month self-pay option.
Prescription issued. Ongoing physician access for dose escalation, side effect management, and progress review.
Frequently asked questions
Everything you need to know about the Wegovy® pill and how FirstCall works.
Wegovy® pill is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Do not use during pregnancy — discontinue at least 2 months before attempting conception. Not recommended during breastfeeding due to the SNAC absorption enhancer. Common side effects include nausea, vomiting, and diarrhea — particularly during dose escalation. Pancreatitis has been reported — seek immediate care for severe abdominal pain. Gallbladder disease risk is increased. Do not take with other semaglutide-containing products. The 30-minute empty stomach rule must be followed for proper absorption.
Other GLP-1 options
Your physician will recommend the most appropriate medication for your profile.
